Table I.
Characteristic | n |
---|---|
Total | 22 (ALK-positive) |
Sex | |
Male | 8 |
Female | 14 |
Age, years | 32–82 (mean, 58.5) |
Smoking status | |
Yes | 8 |
No | 14 |
Histological subtype | 21 adenocarcinoma (21 mucinous carcinoma), 1 undifferentiated carcinoma |
Metastasis | |
Yes | 20 |
No | 2 |
Chemo- or radiation therapy | |
Yes | 22 |
No | 0 |
Additional crizotinib treatment | |
Yes | 15 |
No | 7 |
Current disease status | |
Complete response | 0 |
Stable disease | 8 |
Partial response | 3 |
Progressive disease | 11 |
In total, 23 patients were analyzed (22 patients were ALK-positive, and 1 patient was ALK-negative).